---
figid: PMC7053123__12943_2020_1169_Fig4_HTML
figtitle: Gemcitabine resistance and metabolism
organisms:
- Homo sapiens
- Mus musculus
- Fusconaia subrotunda
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC7053123
filename: 12943_2020_1169_Fig4_HTML.jpg
figlink: pmc/articles/PMC7053123/figure/Fig4/
number: F4
caption: Gemcitabine resistance and metabolism. Gemcitabine and some intrinsic characteristics
  of pancreatic cancer cells produce chemoresistance. Ovals are biological substances,
  rectangles are processes, and hexagons are statuses. Red names indicate corresponding
  inhibitors. Arrows represent positive regulations, and lines with blunt ends represent
  negative regulations. CR, chemoresistance; EMT, epithelial-mesenchymal transition;
  FBP1, fructose-1,6-bisphosphatase 1; IDH1, isocitrate dehydrogenase 1; LAT2, L-type
  amino acid transporter 2; noPPP, nonoxidative pentose phosphate pathway; RRM2, ribonucleotide
  reductase subunit-M2
papertitle: 'Metabolism of pancreatic cancer: paving the way to better anticancer
  strategies.'
reftext: Cheng Qin, et al. Mol Cancer. 2020;19:50.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7962794
figid_alias: PMC7053123__F4
figtype: Figure
redirect_from: /figures/PMC7053123__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7053123__12943_2020_1169_Fig4_HTML.html
  '@type': Dataset
  description: Gemcitabine resistance and metabolism. Gemcitabine and some intrinsic
    characteristics of pancreatic cancer cells produce chemoresistance. Ovals are
    biological substances, rectangles are processes, and hexagons are statuses. Red
    names indicate corresponding inhibitors. Arrows represent positive regulations,
    and lines with blunt ends represent negative regulations. CR, chemoresistance;
    EMT, epithelial-mesenchymal transition; FBP1, fructose-1,6-bisphosphatase 1; IDH1,
    isocitrate dehydrogenase 1; LAT2, L-type amino acid transporter 2; noPPP, nonoxidative
    pentose phosphate pathway; RRM2, ribonucleotide reductase subunit-M2
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AZU1
  - HDLBP
  - SLBP
  - STAM2
  - HEBP1
  - LAT2
  - SLC7A6
  - SLC7A8
  - FASN
  - MTOR
  - PKM
  - PKLR
  - USP9X
  - DECR1
  - ITK
  - SLC22A3
  - IDH1
  - NAMPT
  - MUC1
  - EPHB2
  - MAPK1
  - MAPK3
  - ELAVL1
  - FBP1
  - HIF1A
  - E2F1
  - UBE2L3
  - NFKB1
  - STAT3
  - RBMS1
  - RRM2
  - TP53
  - .na.character
  - Stam2
  - Lat2
  - Slc7a8
  - Slc7a6
  - Fasn
  - Mtor
  - Pkm
  - Usp9x
  - Decr1
  - Itk
  - Slc22a3
  - Idh1
  - Nampt
  - Muc1
  - Ephb2
  - Mapk1
  - Elavl1
  - Fbp1
  - Fbp2
  - Fnbp1
  - Folr1
  - Hif1a
  - E2f1
  - Nfkb1
  - Stat3
  - Rbms1
  - Rrm2
  - Trp53
  - hdlbpa
  - fasn
  - mtor
  - pkma
  - idh1
  - fbp1b
  - fbp1a
  - hif1ab
  - e2f1
  - stat3
  - rrm2
  - rrm2b
  - tp53
  - Chloroquine
  - Orlistat
  - NADPH
  - Gemcitabine
  - NAD
  - FK866
  - Gambolic Acid
  - Pyrimidine
  - leflunomide
  - Digoxin
  - w3 fatty acids
  - Hypoxia
---
